SCHEMBL6684489

SCHEMBL6684489

CCCCCCCCC=CCCCCCCCC(=O)NCCCC

nearest known ligand 0.82

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.82
CNR1 P21554 5/20 0.81
SLC6A5 Q9Y345 2/20 0.79
KDM4E B2RXH2 1/20 0.75
LPAR1 Q92633 1/20 0.75
ALDH1A1 P00352 2/20 0.74
HPGD P15428 2/20 0.74
TRPV1 Q8NER1 1/20 0.74
MEN1 O00255 1/20 0.74
MAPT P10636 1/20 0.74
ALOX12 P18054 1/20 0.74
BLM P54132 1/20 0.74
KMT2A Q03164 1/20 0.74
TDP1 Q9NUW8 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6684484 1.00 EPHX2 (0.82) EPHX2CNR1SLC6A5KDM4ELPAR1
SCHEMBL9517153 1.00 EPHX2 (0.82) EPHX2CNR1SLC6A5KDM4ELPAR1
SCHEMBL9517142 1.00 EPHX2 (0.82) EPHX2CNR1SLC6A5KDM4ELPAR1
SCHEMBL16622191 1.00 EPHX2 (0.82) EPHX2CNR1SLC6A5KDM4ELPAR1
SCHEMBL4950693 1.00 EPHX2 (0.82) EPHX2CNR1SLC6A5KDM4ELPAR1
SCHEMBL15220082 0.98 EPHX2 (0.79) EPHX2CNR1SLC6A5KDM4ELPAR1
SCHEMBL25334864 0.96 EPHX2 (0.88) EPHX2CNR1SLC6A5KDM4ELPAR1
SCHEMBL395220 0.96 EPHX2 (0.88) EPHX2CNR1SLC6A5KDM4ELPAR1
SCHEMBL2088277 0.96 EPHX2 (0.88) EPHX2CNR1SLC6A5KDM4ELPAR1
SCHEMBL22716596 0.96 EPHX2 (0.88) EPHX2CNR1SLC6A5KDM4ELPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT THE PILOT INK CO., LTD. (JP) 2026-03-05 US disclosed
US-12460099-B2 Reversibly thermochromic composition, reversibly thermochromic microcapsule pigment encapsulating reversibly thermochromic composition, and writing instrument using reversibly thermochromic microcapsule pigment THE PILOT INK CO., LTD. (JP) 2025-11-04 US disclosed
EP-3608386-B1 REVERSIBLY THERMOCHROMIC COMPOSITION, AND REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT HAVING SAME ENCLOSED THEREIN PILOT INK CO LTD (JP) 2025-02-19 EP disclosed
US-12123107-B2 Reversibly thermochromic composite fiber KABUSHIKI KAISHA PILOT CORPORATION (JP) 2024-10-22 US disclosed
US-20220169919-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT THE PILOT INK CO., LTD. (JP) 2022-06-02 US disclosed
EP-3950068-A1 REVERSIBLE THERMOCHROMIC COMPOSITION, REVERSIBLE THERMOCHROMIC MICROCAPSULE PIGMENT COMPRISING SAME, AND WRITING INSTRUMENT USING SAME THE PILOT INK CO., LTD. (JP) 2022-02-09 EP disclosed
US-20210355608-A1 REVERSIBLY THERMOCHROMIC COMPOSITE FIBER THE PILOT INK CO., LTD. (JP) 2021-11-18 US disclosed
US-11060018-B2 Reversibly thermochromic composition and reversibly thermochromic microcapsule pigment encapsulating the same THE PILOT INK CO., LTD. (JP) 2021-07-13 US disclosed
US-20200048542-A1 REVERSIBLY THERMOCHROMIC COMPOSITION AND REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING THE SAME THE PILOT INK CO., LTD. (JP) 2020-02-13 US disclosed
EP-3608386-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, AND REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT HAVING SAME ENCLOSED THEREIN The Pilot Ink Co., Ltd (JP) 2020-02-12 EP disclosed
EP-0908501-B1 Reversible thermochromic composition PILOT INK CO LTD (JP) 2003-07-09 EP disclosed
US-6494950-B1 FOUR ESSENTIAL COMPONENTS (A) AN ELECTRON-DONATING CHROMATIC ORGANIC COMPOUND, (B) AN ELECTRON-ACCEPTING COMPOUND, (C) A REACTION MEDIUM DETERMINING THE TEMPERATURES AT WHICH THE COLOR REACTIONS OF COMPONENT (A) WITH COMPONENT (B) TAKE THE PILOT INK CO., LTD. (JP) 2002-12-17 US disclosed
EP-0873881-B1 Reversible thermochromic compositions PILOT INK CO LTD (JP) 2001-10-17 EP disclosed
EP-1084860-A2 Thermochromic microencapsulated pigments THE PILOT INK CO., LTD. (JP) 2001-03-21 EP disclosed
US-6048387-A SPECIFIED DIAZARHODAMINE LACTONE DERIVATIVE AS AN ELECTRON-DONATING COLOR-DEVELOPING ORGANIC COMPOUND THE PILOT INK CO., LTD. (JP) 2000-04-11 US disclosed
US-5919404-A MIXTURE OF COLOR DEVELOPING COMPOUND AND ELECTRON ACCEPTORALKOXYPHENOL COMPOUND THE PILOT INK CO., LTD. (JP) 1999-07-06 US disclosed
EP-0908501-A1 Reversible thermochromic composition THE PILOT INK CO., LTD. (JP) 1999-04-14 EP disclosed
EP-0873881-A1 Reversible thermochromic compositions The Pilot Ink CO., Ltd. (JP) 1998-10-28 EP disclosed
US-4410509-A NONHYDROCARBON 9-TRICOSENE DERIVATIVES TRUSTEES OF DAVIDSON COLLEGE (US) 1983-10-18 US disclosed
US-3963570-A Ultraviolet-initiated preparation of N,N-dibutyl-9(10)-dibutylphosphonooctadecanamide THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1976-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT TYR, SCO2, HBB EPHX2 2279/4885CNR1 4862/4885SLC6A5 4135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.